Stockreport

Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCV [Yahoo! Finance]

Danaher Corporation  (DHR) 
Last danaher corporation earnings: 1/30 06:00 am Check Earnings Report
US:NYSE Investor Relations: investors.danaher.com
PDF received FDA De Novo marketing authorization and Clinical Laboratory Improvement Amendments (CLIA) Waiver approval for Xpert ® HCV, the only molecular test in the US to [Read more]